FEB 14, 2018
Glaucoma 360, 2018
Glaucoma, Medical Therapy
In this interview from Glaucoma 360, Dr. Jamie Brandt, MD, discuss developments in glaucoma drug delivery. The main problem with glaucoma drops is compliance, and sustained delivery devices offer a path to improving patient compliance. Implants are not without issues, however. Dr. Brandt foresees possible problems with potential side effects and for patients who are on more than 1 medication. He also discusses how home monitoring could one day revolutionize the management of this disease.
Relevant Financial Disclosures: None